Published April 2, 2026 | Version v1

From Chaos To Clarity: The Pharmacists Hand In Psychiatric Polypharmacy

Authors/Creators

Description

Polypharmacy, defined as the concurrent use of multiple medications, is a prevalent challenge in psychiatric care, with reported rates ranging from 13% to 90% across diverse clinical settings. This practice, particularly common in managing complex psychiatric disorders such as schizophrenia and bipolar disorder, is associated with increased risks of adverse drug reactions, drug-drug interactions, nonadherence, and substantial healthcare costs. Pharmacists are instrumental in optimizing polypharmacy management through comprehensive medication reviews, therapeutic drug monitoring, and pharmacogenomic-guided interventions. By streamlining regimens, enhancing patient adherence, and fostering collaboration within multidisciplinary teams, pharmacists mitigate clinical risks and alleviate economic burdens. Emerging technologies, including clinical decision support systems, tele pharmacy, and artificial intelligence, further amplify their ability to enhance medication safety and improve access to care. This article examines the multifaceted challenges of psychiatric polypharmacy, underscores the critical role of pharmacists, and explores future directions, including the establishment of specialized psychiatric pharmacy clinics and the integration of pharmacogenomics, to promote safer, more effective, and equitable mental health care delivery.

Files

38- S DEVIKA JPS0202109 comp.pdf

Files (495.9 kB)

Name Size
md5:8be715fd71ef9c05fa1cdabcc2f3343d
495.9 kB Preview Download